Global Cell Therapy Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	166 Pages	TechNavio	August, 2024	INF19175872

Best Price Guarantee
Price	from $2,500
Length	166 Pages
Publisher	TechNavio
Published Date	August, 2024
SKU	INF19175872

Global Cell Therapy Market 2024-2028

The cell therapy market is forecasted to grow by USD 84584.7 mn during 2023-2028, accelerating at a CAGR of 73.89% during the forecast period. The report on the cell therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by limitations in traditional organ transplantations fueling demand for cell therapies, increasing funding in cell-based research, and proven effectiveness of car t-cell therapy.

Technavio's cell therapy market is segmented as below:

By Type

Autologous
Allogenic

By Application

Malignancies
Musculoskeletal
Cardiovascular
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing focus on cell therapy products as one of the prime reasons driving the cell therapy market growth during the next few years. Also, strategic alliances in cell therapy market and rise in vaccine production will lead to sizable demand in the market.

The report on the cell therapy market covers the following areas:

Cell therapy market sizing
Cell therapy market forecast
Cell therapy market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cell therapy market vendors that include Astellas Pharma Inc., Athersys Inc., Avita Medical Inc., BioCardia Inc., BioSenic SA, Brainstorm Cell Therapeutics Inc., Bristol Myers Squibb Co., Capricor Therapeutics Inc., Castle Creek Biosciences Inc., CellSeed Inc., Cellular Biomedicine Group Inc., Celyad Oncology SA, Gilead Sciences Inc., Lineage Cell Therapeutics Inc., Lisata Therapeutics Inc., Mesoblast Ltd., Novartis AG, Pharmicell Co. Ltd., Sanpower Group Co. Ltd., and ThermoGenesis Holdings Inc.. Also, the cell therapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Market Segmentation by Application; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Cell Therapy Market 2018 - 2022; Historic Market Size - Data Table on Global Cell Therapy Market 2018 - 2022 ($ million); 4.2 Type segment analysis 2018 - 2022; Historic Market Size - Type Segment 2018 - 2022 ($ million); 4.3 Application segment analysis 2018 - 2022; Historic Market Size - Application Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type: 6.1 Market segments; Chart on Type - Market share 2023-2028 (%); Data Table on Type - Market share 2023-2028 (%); 6.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 6.3 Autologous - Market size and forecast 2023-2028; Chart on Autologous - Market size and forecast 2023-2028 ($ million); Data Table on Autologous - Market size and forecast 2023-2028 ($ million); Chart on Autologous - Year-over-year growth 2023-2028 (%); Data Table on Autologous - Year-over-year growth 2023-2028 (%); 6.4 Allogenic - Market size and forecast 2023-2028; Chart on Allogenic - Market size and forecast 2023-2028 ($ million); Data Table on Allogenic - Market size and forecast 2023-2028 ($ million); Chart on Allogenic - Year-over-year growth 2023-2028 (%); Data Table on Allogenic - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by Type; Market opportunity by Type ($ million); Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Application: 7.1 Market segments; Chart on Application - Market share 2023-2028 (%); Data Table on Application - Market share 2023-2028 (%); 7.2 Comparison by Application; Chart on Comparison by Application; Data Table on Comparison by Application; 7.3 Malignancies - Market size and forecast 2023-2028; Chart on Malignancies - Market size and forecast 2023-2028 ($ million); Data Table on Malignancies - Market size and forecast 2023-2028 ($ million); Chart on Malignancies - Year-over-year growth 2023-2028 (%); Data Table on Malignancies - Year-over-year growth 2023-2028 (%); 7.4 Musculoskeletal - Market size and forecast 2023-2028; Chart on Musculoskeletal - Market size and forecast 2023-2028 ($ million); Data Table on Musculoskeletal - Market size and forecast 2023-2028 ($ million); Chart on Musculoskeletal - Year-over-year growth 2023-2028 (%); Data Table on Musculoskeletal - Year-over-year growth 2023-2028 (%); 7.5 Cardiovascular - Market size and forecast 2023-2028; Chart on Cardiovascular - Market size and forecast 2023-2028 ($ million); Data Table on Cardiovascular - Market size and forecast 2023-2028 ($ million); Chart on Cardiovascular - Year-over-year growth 2023-2028 (%); Data Table on Cardiovascular - Year-over-year growth 2023-2028 (%); 7.6 Others - Market size and forecast 2023-2028; Chart on Others - Market size and forecast 2023-2028 ($ million); Data Table on Others - Market size and forecast 2023-2028 ($ million); Chart on Others - Year-over-year growth 2023-2028 (%); Data Table on Others - Year-over-year growth 2023-2028 (%); 7.7 Market opportunity by Application; Market opportunity by Application ($ million); Data Table on Market opportunity by Application ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.9 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ million); Data Table on UK - Market size and forecast 2023-2028 ($ million); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 9.10 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.11 Japan - Market size and forecast 2023-2028; Chart on Japan - Market size and forecast 2023-2028 ($ million); Data Table on Japan - Market size and forecast 2023-2028 ($ million); Chart on Japan - Year-over-year growth 2023-2028 (%); Data Table on Japan - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 Astellas Pharma Inc.; Astellas Pharma Inc. - Overview; Astellas Pharma Inc. - Product / Service; Astellas Pharma Inc. - Key news; Astellas Pharma Inc. - Key offerings; 12.4 Athersys Inc.; Athersys Inc. - Overview; Athersys Inc. - Product / Service; Athersys Inc. - Key offerings; 12.5 Avita Medical Inc.; Avita Medical Inc. - Overview; Avita Medical Inc. - Product / Service; Avita Medical Inc. - Key offerings; 12.6 BioCardia Inc.; BioCardia Inc. - Overview; BioCardia Inc. - Product / Service; BioCardia Inc. - Key offerings; 12.7 BioSenic SA; BioSenic SA - Overview; BioSenic SA - Product / Service; BioSenic SA - Key offerings; 12.8 Brainstorm Cell Therapeutics Inc.; Brainstorm Cell Therapeutics Inc. - Overview; Brainstorm Cell Therapeutics Inc. - Product / Service; Brainstorm Cell Therapeutics Inc. - Key offerings; 12.9 Bristol Myers Squibb Co.; Bristol Myers Squibb Co. - Overview; Bristol Myers Squibb Co. - Product / Service; Bristol Myers Squibb Co. - Key news; Bristol Myers Squibb Co. - Key offerings; 12.10 Capricor Therapeutics Inc.; Capricor Therapeutics Inc. - Overview; Capricor Therapeutics Inc. - Product / Service; Capricor Therapeutics Inc. - Key offerings; 12.11 Castle Creek Biosciences Inc.; Castle Creek Biosciences Inc. - Overview; Castle Creek Biosciences Inc. - Product / Service; Castle Creek Biosciences Inc. - Key offerings; 12.12 CellSeed Inc.; CellSeed Inc. - Overview; CellSeed Inc. - Product / Service; CellSeed Inc. - Key offerings; 12.13 Cellular Biomedicine Group Inc.; Cellular Biomedicine Group Inc. - Overview; Cellular Biomedicine Group Inc. - Product / Service; Cellular Biomedicine Group Inc. - Key offerings; 12.14 Celyad Oncology SA; Celyad Oncology SA - Overview; Celyad Oncology SA - Product / Service; Celyad Oncology SA - Key offerings; 12.15 Gilead Sciences Inc.; Gilead Sciences Inc. - Overview; Gilead Sciences Inc. - Product / Service; Gilead Sciences Inc. - Key news; Gilead Sciences Inc. - Key offerings; 12.16 Lineage Cell Therapeutics Inc.; Lineage Cell Therapeutics Inc. - Overview; Lineage Cell Therapeutics Inc. - Product / Service; Lineage Cell Therapeutics Inc. - Key offerings; 12.17 Lisata Therapeutics Inc.; Lisata Therapeutics Inc. - Overview; Lisata Therapeutics Inc. - Product / Service; Lisata Therapeutics Inc. - Key offerings
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Type; Exhibits6: Executive Summary - Chart on Market Segmentation by Application; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Cell Therapy Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Type Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Application Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on Type - Market share 2023-2028 (%); Exhibits33: Data Table on Type - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by Type; Exhibits35: Data Table on Comparison by Type; Exhibits36: Chart on Autologous - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on Autologous - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on Autologous - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Autologous - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Allogenic - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on Allogenic - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on Allogenic - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Allogenic - Year-over-year growth 2023-2028 (%); Exhibits44: Market opportunity by Type ($ million); Exhibits45: Data Table on Market opportunity by Type ($ million); Exhibits46: Chart on Application - Market share 2023-2028 (%); Exhibits47: Data Table on Application - Market share 2023-2028 (%); Exhibits48: Chart on Comparison by Application; Exhibits49: Data Table on Comparison by Application; Exhibits50: Chart on Malignancies - Market size and forecast 2023-2028 ($ million); Exhibits51: Data Table on Malignancies - Market size and forecast 2023-2028 ($ million); Exhibits52: Chart on Malignancies - Year-over-year growth 2023-2028 (%); Exhibits53: Data Table on Malignancies - Year-over-year growth 2023-2028 (%); Exhibits54: Chart on Musculoskeletal - Market size and forecast 2023-2028 ($ million); Exhibits55: Data Table on Musculoskeletal - Market size and forecast 2023-2028 ($ million); Exhibits56: Chart on Musculoskeletal - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on Musculoskeletal - Year-over-year growth 2023-2028 (%); Exhibits58: Chart on Cardiovascular - Market size and forecast 2023-2028 ($ million); Exhibits59: Data Table on Cardiovascular - Market size and forecast 2023-2028 ($ million); Exhibits60: Chart on Cardiovascular - Year-over-year growth 2023-2028 (%); Exhibits61: Data Table on Cardiovascular - Year-over-year growth 2023-2028 (%); Exhibits62: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibits63: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibits64: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits65: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits66: Market opportunity by Application ($ million); Exhibits67: Data Table on Market opportunity by Application ($ million); Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits69: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits70: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits71: Chart on Geographic comparison; Exhibits72: Data Table on Geographic comparison; Exhibits73: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits74: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits75: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits101: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits102: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits103: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits104: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits105: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibits106: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibits107: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits108: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits109: Market opportunity By Geographical Landscape ($ million); Exhibits110: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits111: Impact of drivers and challenges in 2023 and 2028; Exhibits112: Overview on criticality of inputs and factors of differentiation; Exhibits113: Overview on factors of disruption; Exhibits114: Impact of key risks on business; Exhibits115: Companies covered; Exhibits116: Matrix on companies position and classification; Exhibits117: Astellas Pharma Inc. - Overview; Exhibits118: Astellas Pharma Inc. - Product / Service; Exhibits119: Astellas Pharma Inc. - Key news; Exhibits120: Astellas Pharma Inc. - Key offerings; Exhibits121: Athersys Inc. - Overview; Exhibits122: Athersys Inc. - Product / Service; Exhibits123: Athersys Inc. - Key offerings; Exhibits124: Avita Medical Inc. - Overview; Exhibits125: Avita Medical Inc. - Product / Service; Exhibits126: Avita Medical Inc. - Key offerings; Exhibits127: BioCardia Inc. - Overview; Exhibits128: BioCardia Inc. - Product / Service; Exhibits129: BioCardia Inc. - Key offerings; Exhibits130: BioSenic SA - Overview; Exhibits131: BioSenic SA - Product / Service; Exhibits132: BioSenic SA - Key offerings; Exhibits133: Brainstorm Cell Therapeutics Inc. - Overview; Exhibits134: Brainstorm Cell Therapeutics Inc. - Product / Service; Exhibits135: Brainstorm Cell Therapeutics Inc. - Key offerings; Exhibits136: Bristol Myers Squibb Co. - Overview; Exhibits137: Bristol Myers Squibb Co. - Product / Service; Exhibits138: Bristol Myers Squibb Co. - Key news; Exhibits139: Bristol Myers Squibb Co. - Key offerings; Exhibits140: Capricor Therapeutics Inc. - Overview; Exhibits141: Capricor Therapeutics Inc. - Product / Service; Exhibits142: Capricor Therapeutics Inc. - Key offerings; Exhibits143: Castle Creek Biosciences Inc. - Overview; Exhibits144: Castle Creek Biosciences Inc. - Product / Service; Exhibits145: Castle Creek Biosciences Inc. - Key offerings; Exhibits146: CellSeed Inc. - Overview; Exhibits147: CellSeed Inc. - Product / Service; Exhibits148: CellSeed Inc. - Key offerings; Exhibits149: Cellular Biomedicine Group Inc. - Overview; Exhibits150: Cellular Biomedicine Group Inc. - Product / Service; Exhibits151: Cellular Biomedicine Group Inc. - Key offerings; Exhibits152: Celyad Oncology SA - Overview; Exhibits153: Celyad Oncology SA - Product / Service; Exhibits154: Celyad Oncology SA - Key offerings; Exhibits155: Gilead Sciences Inc. - Overview; Exhibits156: Gilead Sciences Inc. - Product / Service; Exhibits157: Gilead Sciences Inc. - Key news; Exhibits158: Gilead Sciences Inc. - Key offerings; Exhibits159: Lineage Cell Therapeutics Inc. - Overview; Exhibits160: Lineage Cell Therapeutics Inc. - Product / Service; Exhibits161: Lineage Cell Therapeutics Inc. - Key offerings; Exhibits162: Lisata Therapeutics Inc. - Overview; Exhibits163: Lisata Therapeutics Inc. - Product / Service; Exhibits164: Lisata Therapeutics Inc. - Key offerings; Exhibits165: Inclusions checklist; Exhibits166: Exclusions checklist; Exhibits167: Currency conversion rates for US$; Exhibits168: Research methodology; Exhibits169: Information sources; Exhibits170: Data validation; Exhibits171: Validation techniques employed for market sizing; Exhibits172: Data synthesis; Exhibits173: 360 degree market analysis; Exhibits174: List of abbreviations